These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20558460)

  • 1. Cardiac conditioning: a review of evolving strategies to reduce ischaemia-reperfusion injury.
    Kharbanda RK
    Heart; 2010 Aug; 96(15):1179-86. PubMed ID: 20558460
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolving story of "conditioning" to protect against acute myocardial ischaemia-reperfusion injury.
    Hausenloy DJ; Yellon DM
    Heart; 2007 Jun; 93(6):649-51. PubMed ID: 17502643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efforts to reduce myocardial infarct size--the next step.
    Braunwald E
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):349-53. PubMed ID: 21821538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac pre- and post-conditioning: implications in anesthesia?
    Pesonen E
    Acta Anaesthesiol Scand; 2010 Aug; 54(7):793-4. PubMed ID: 20649515
    [No Abstract]   [Full Text] [Related]  

  • 6. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcolemmal permeability changes during ischaemia and reperfusion: release of survival factors.
    Lochner A
    Cardiovasc Res; 2008 Sep; 79(4):545-6. PubMed ID: 18596058
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning.
    Skyschally A; Schulz R; Heusch G
    Herz; 2008 Mar; 33(2):88-100. PubMed ID: 18344027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial ischaemia/reperfusion injury and preconditioning: effects of hypercholesterolaemia/hyperlipidaemia.
    Ferdinandy P
    Br J Pharmacol; 2003 Jan; 138(2):283-5. PubMed ID: 12540517
    [No Abstract]   [Full Text] [Related]  

  • 10. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection.
    Shimizu M; Tropak M; Diaz RJ; Suto F; Surendra H; Kuzmin E; Li J; Gross G; Wilson GJ; Callahan J; Redington AN
    Clin Sci (Lond); 2009 Aug; 117(5):191-200. PubMed ID: 19175358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischaemia, reperfusion, pre-and post-conditioning: telling friend from foe.
    Bondke Persson A; Persson PB
    Acta Physiol (Oxf); 2012 Nov; 206(3):157-9. PubMed ID: 23017102
    [No Abstract]   [Full Text] [Related]  

  • 12. [Conditioning the heart in cardiac surgery].
    Deja MA; Malinowski M
    Kardiol Pol; 2011; 69 Suppl 3():80-4. PubMed ID: 22125208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.
    Hausenloy D; Wynne A; Duchen M; Yellon D
    Circulation; 2004 Apr; 109(14):1714-7. PubMed ID: 15066952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical perspectives on reperfusion injury in acute myocardial infarction.
    Bainey KR; Armstrong PW
    Am Heart J; 2014 May; 167(5):637-45. PubMed ID: 24766972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective signalling: Past, present and future.
    Jovanović A
    Eur J Pharmacol; 2018 Aug; 833():314-319. PubMed ID: 29935170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger.
    Bouwman RA; Salic K; Padding FG; Eringa EC; van Beek-Harmsen BJ; Matsuda T; Baba A; Musters RJ; Paulus WJ; de Lange JJ; Boer C
    Circulation; 2006 Jul; 114(1 Suppl):I226-32. PubMed ID: 16820577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection by volatile anesthetics.
    Bienengraeber MW; Weihrauch D; Kersten JR; Pagel PS; Warltier DC
    Vascul Pharmacol; 2005; 42(5-6):243-52. PubMed ID: 15922257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remote conditioning: the future of cardioprotection?
    Heusch G
    J Cardiovasc Med (Hagerstown); 2013 Mar; 14(3):176-9. PubMed ID: 23412365
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.